$1.60
-0.02 (-1.23%)
Open$1.65
Previous Close$1.62
Day High$1.68
Day Low$1.60
52W High$26.36
52W Low$13.37
Volume—
Avg Volume589.9K
Market Cap78.63M
P/E Ratio43.04
EPS$0.56
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,681.3% upside
Current
$1.60
$1.60
Target
$28.50
$28.50
$17.57
$28.50 avg
$41.49
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 11.04M | 11.56M | 10.16M |
| Net Income | -536,425 | -578,623 | -557,404 |
| Profit Margin | -4.9% | -5.0% | -5.5% |
| EBITDA | -810,707 | -735,622 | -650,086 |
| Free Cash Flow | -370,627 | -351,629 | -405,371 |
| Rev Growth | +9.7% | -0.5% | +16.2% |
| Debt/Equity | 0.96 | 0.89 | 0.88 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |